Search results
With FDA Clearance, Intuitive Surgical Operates On New Breakout
Investor's Business Daily· 6 hours agoIntuitive Surgical Leads, But Challenges (And Challengers) Arise In March, the FDA provided...
Psychoactive drugs are having a moment. The FDA will soon weigh in
The Desert Sun· 3 hours agoLori Tipton is among the growing number of people who say that MDMA, also known as ecstasy, saved...
Ro launches GLP-1 tracker amid ongoing shortage
Crain's New York Business· 12 hours agoRo said its tracker may be an alternative to relying on the FDA's drug shortage list, as that list only includes drugs by active ingredient and not brand name. The
FDA Approves Elanco's Methane-Reducing Cattle Feed Additive By Investing.com
Investing.com· 1 day agoElanco Animal Health Incorporated (NYSE:ELAN) has received approval from the U.S. Food and Drug...
FDA approves Terumo’s CDI OneView Monitoring System
Medical Device Network via Yahoo Finance· 18 hours agoThe US Food and Drug Administration (FDA) has granted 510(k) clearance for Terumo Cardiovascular’s CDI OneView Monitoring System, which aims to enhance...
FDA clears Inspira Technologies' Bypass System By Investing.com
Investing.com· 1 day ago(NASDAQ:IINN) (NASDAQ:IINNW), known for its medical technology innovations, announced today that it...
FDA approves new tool to enhance cataract surgery outcomes
KTBS Shreveport· 16 hours agoThe US Food and Drug Administration (FDA) has qualified the American Academy of Ophthalmology’s...
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
Digital Journal· 15 hours ago(Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that the United States Food and Drug Administration ...
Nearly 1.9 million bottles of water impacted by FDA recall pose ‘no health or safety risk’: company
WPIX New York City, NY via Yahoo News· 4 days agoThe FDA has determined thousands of cases of bottled water affected by a March recall are "not...
Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag
Zacks· 21 hours agoThe FDA grants priority review to Roche's (RHHBY) NDA for the inavolisib combination regimen for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.